Question 1

Berapa harga saham Kenvue. hari ini?

Accepted Answer

Harga saat ini dari Kenvue. adalah 18.60 USD — telah menurun sebesar -0.77% dalam 24 jam terakhir. Lihat kinerja harga saham Kenvue. lebih dekat di chart lanjutan.

Question 2

Apa simbol saham Kenvue.?

Accepted Answer

Tergantung pada bursa, simbol saham dapat bervariasi. Misalnya, di bursa NYSE, saham Kenvue. diperdagangkan dengan simbol KVUE.

Question 3

Apakah harga saham KVUE naik?

Accepted Answer

Saham KVUE telah meningkat sebesar 3.22% dalam minggu terakhir, telah meningkat sebesar 6.01% dalam bulan terakhir, dan telah menurun sebesar -12.22% dalam setahun terakhir. Lihat lebih banyak data di KVUE chart.

Question 4

Apa rekomendasi analis untuk KVUE?

Accepted Answer

Per tanggal 25 Jun 2026, dari 12 rekomendasi analis, mayoritas memberikan nilai KVUE sebagai hold.

Question 5

Berapa kapitalisasi pasar KVUE?

Accepted Answer

Hingga hari ini, KVUE memiliki kapitalisasi pasar sebesar 34.79B USD. Jelajahi daftar saham kami yang diperingkat berdasarkan kapitalisasi pasar untuk membandingkan KVUE dengan saham lainnya.

Question 6

Apakah KVUE merilis laporan keuangan?

Accepted Answer

Ya, Anda dapat melacak keuangan KVUE dalam laporan tahunan dan kuartalan di Profit.com.

Question 7

Kapan tanggal laporan pendapatan KVUE berikutnya?

Accepted Answer

KVUE akan merilis laporan pendapatan berikutnya pada 06 Agt 2026. Ikuti perkembangan acara mendatang dengan Kalender Pendapatan kami.

Question 8

Berapa pendapatan KVUE untuk kuartal terakhir?

Accepted Answer

KVUE melaporkan pendapatan sebesar $0.32 per saham untuk kuartal terakhir, lebih tinggi dibandingkan dengan estimasi $0.26 per saham, menghasilkan kejutan 23.08%. Pendapatan yang diperkirakan untuk kuartal berikutnya adalah $0.32 per saham. Lihat lebih banyak detail tentang pendapatan KVUE di Profit.com.

Question 9

Berapa pendapatan KVUE untuk kuartal terakhir?

Accepted Answer

Pendapatan KVUE untuk kuartal terakhir adalah 3.91B USD, lebih tinggi dibandingkan dengan estimasi 3.89B USD. Pendapatan yang diperkirakan untuk kuartal berikutnya adalah 3.91B USD. Lihat lebih banyak statistik di KVUE laporan keuangan di Profit.com.

Question 10

Berapa Laba Bersih KVUE untuk kuartal terakhir?

Accepted Answer

Laba bersih KVUE untuk kuartal terakhir adalah 474M USD, sementara kuartal sebelumnya menunjukkan laba bersih 330M USD yang mencatatkan perubahan sebesar 43.64%. Lihat lebih banyak statistik di KVUE laporan keuangan di Profit.com.

Question 11

Apakah KVUE membayar dividen?

Accepted Answer

Ya, dividen KVUE dibayar setiap kuartal. Dividen terakhir per saham adalah 0.828. Hingga hari ini, Dividend Yield (TTM)% adalah 4.57%.

Question 12

Berapa banyak karyawan yang dimiliki KVUE?

Accepted Answer

Hingga 25 Jun 2026, KVUE mempekerjakan sekitar 21780 karyawan. Periksa apakah KVUE ada dalam daftar pengusaha terbesar kami.

Question 13

Apa itu EBITDA KVUE?

Accepted Answer

EBITDA, yang mengukur kinerja operasional perusahaan, mencerminkan peningkatan efisiensinya. EBITDA KVUE adalah 3.47B USD, dengan margin EBITDA saat ini sebesar 10.61%. Lihat lebih banyak statistik di laporan keuangan KVUE di Profit.com.

Question 14

Bagaimana cara membeli saham KVUE?

Accepted Answer

Seperti saham lainnya, saham KVUE diperdagangkan di bursa saham seperti NYSE. Cara termudah untuk membelinya adalah melalui broker saham online. Cukup buka akun, ikuti prosedur broker, dan mulai berdagang. Sebagai alternatif, Anda dapat berlatih berdagang saham Tesla di Profit.com dalam Turnamen Playtrade atau memilih broker yang disarankan untuk berdagang langsung.

Question 15

Haruskah saya berinvestasi di saham KVUE?

Accepted Answer

Berinvestasi di saham membutuhkan penelitian yang mendalam, termasuk menganalisis keuangan perusahaan, berita terkait, dan analisis teknis. Saat ini, rekomendasi analis teknis Tesla menunjukkan rating hold.

Sebelum berinvestasi di KVUE, pertimbangkan untuk berlangganan Profit PRO di mana Anda dapat berlatih berdagang di Turnamen Playtrade, mengakses wawasan pasar harian berbasis AI, menyalin Watchlist yang dipilih dengan ahli, dan mengikuti Portofolio Miliarder.

Kenvue Inc.

Chinese regulator asks fore more information in Kenvue-Kimberly Clark deal - report

Kimberly-Clark acquisition of Kenvue gains ISS recommendation

Key deals this week: Kenvue, Warner Bros. Discovery, Adobe, Workday and more

Kenvue gains amid speculation on potential rival bidder

Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link

*TRUMP: TYLENOL CAN BE ASSOCIATED WITH INCREASED AUTISM RISK *TRUMP: TAKING TYLENOL IS NOT GOOD $KVUE https://t.co/Z5rfylHjCH

Kenvue says Tylenol is safe, but stock hits record low ahead of Trump speech

4 stocks to watch on Friday: KVUE, WBD, BA, MSFT

*RFK JR, HHS TO LINK AUTISM TO TYLENOL USE IN PREGNANCY: WSJ *RFK JR. TO ANNOUNCE FOLINIC ACID MAY CUT SYMPTOMS OF AUTISM:WSJ *RFK JR, HHS TO ALSO LINK AUTISM TO LOW FOLATE LEVELS: WSJ $KVUE https://t.co/LG0QYURXvK

Kenvue fights back against Tylenol safety concerns as its stock tumbles

Kenvue CEO steps down amid board's strategic review - CNBC

Kenvue settles proxy fight with activist Starboard, adding three directors to its board

Kenvue gains amid takeover speculation

Kenvue gains on report activist Starboard nominates five for board

Activist Starboard could push for Kenvue to sell some/all of its SBH business - analyst

Kenvue shares surge after activist Starboard takes stake

Starboard reportedly takes big stake in Tylenol maker Kenvue

David Einhorn’s Greenlight Capital adds Kenvue, ETFs and exits Southwestern Energy

Kenvue may be activist target amid recent 13-F filing

Here are 16 stocks Jim Cramer is watching, including J&J split-off Kenvue, Petco, GM

Kenvue, the J&J spinoff, will join the S&P 500 index

Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer

Johnson & Johnson launches Kenvue exchange offer (NYSE:JNJ) - Seeking Alpha

J&J's strong quarter was amplified by new details around its big Kenvue consumer unit stake

Kenvue earnings top estimates in J&J spinoff's first quarterly report since IPO

Kenvue CEO looks to brand, product innovation to drive growth after IPO

Johnson & Johnson's consumer health unit Kenvue started trading. What it means for J&J shareholders like us - CNBC

IPO Report: Kenvue stock cheered in Wall Street debut, as Tylenol and Band-Aid brand parent is valued at $48 billion

J&J's consumer-health spinoff Kenvue jumps 22% in public market debut - CNBC

J&J's Kenvue prices upsized IPO at upper end of range to raise $3.8 bln https://t.co/WCFBZBvvEa https://t.co/Uxt1PMW6hJ

J&J's Kenvue prices upsized IPO at upper end of range to raise $3.8 bln https://t.co/XIgT90hakj https://t.co/2v2s5xgsOj

IPO Report: Johnson & Johnson’s Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021

J&J's Kenvue prices upsized IPO at upper end of range to raise $3.7 bln -sources https://t.co/UKirJ3xBPF https://t.co/S7Pkec9591

J&J's consumer health business Kenvue is going public this week. Here's what to know

IPO Report: J&J’s Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021

The claims come days before Kenvue, J&J's consumer spin-off, attempts to complete the largest US initial public offering in more than a year. https://t.co/PtzNe1c3g8 https://t.co/WSVfeTDsfY

J&J aims for up to $43 bln valuation for consumer health unit Kenvue https://t.co/fEMYnWagND https://t.co/BGSBTMuSLF

Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO - CNBC

J&J's consumer health unit Kenvue files for IPO, moving closer to spin-off https://t.co/6EPDbX4AJj https://t.co/jEvhPe07B5

J&J's consumer health unit Kenvue files for IPO, moving closer to spin-off https://t.co/Y8HhRS6aTx https://t.co/rJtmLjhBMs

J&J names consumer health business Kenvue ahead of spin-off https://t.co/kPdNfbL0xp https://t.co/2mmiEzY8Ix

J&J names consumer health business Kenvue ahead of spin-off https://t.co/7MVYDk3a3o https://t.co/94Em4UZesa

FAQ

TRUMP: TYLENOL CAN BE ASSOCIATED WITH INCREASED AUTISM RISK TRUMP: TAKING TYLENOL IS NOT GOOD $KVUE https://t.co/Z5rfylHjCH

RFK JR, HHS TO LINK AUTISM TO TYLENOL USE IN PREGNANCY: WSJ RFK JR. TO ANNOUNCE FOLINIC ACID MAY CUT SYMPTOMS OF AUTISM:WSJ *RFK JR, HHS TO ALSO LINK AUTISM TO LOW FOLATE LEVELS: WSJ $KVUE https://t.co/LG0QYURXvK